These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18514858)

  • 1. Regarding "A novel molecular mechanism to account for the action of simvastatin against limb ischemia".
    Namazi H
    J Vasc Surg; 2008 Jun; 47(6):1378; author reply 1378. PubMed ID: 18514858
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin pretreatment reduces the severity of limb ischemia in an experimental diabetes model.
    Köksoy C; Oziş E; Cakmak A; Yazgan U; Okcu-Heper A; Köksoy A; Demirpençe E; Deniz Dinçer U
    J Vasc Surg; 2007 Mar; 45(3):590-6. PubMed ID: 17257798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins inhibit neutrophil infiltration in skeletal muscle reperfusion injury.
    Cowled PA; Khanna A; Laws PE; Field JB; Varelias A; Fitridge RA
    J Surg Res; 2007 Aug; 141(2):267-76. PubMed ID: 17559881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing the expression of LFA-1 and ICAM-1 as well as hindering their interaction as the major mechanism for statin-induced neutrophil dysfunction.
    Namazi MR
    Ann Thorac Surg; 2007 Dec; 84(6):2137-8. PubMed ID: 18036969
    [No Abstract]   [Full Text] [Related]  

  • 5. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
    Rydgren T; Sandler S
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
    Maher BM; Dhonnchu TN; Burke JP; Soo A; Wood AE; Watson RW
    J Leukoc Biol; 2009 Jan; 85(1):186-93. PubMed ID: 18840670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiinflammatory effects of statins.
    McCarey DW; McInnes IB; Sattar N
    N Engl J Med; 2001 Oct; 345(16):1209-10; author reply 1210-1. PubMed ID: 11642240
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin in traumatic brain injury: effect on brain edema mechanisms.
    Béziaud T; Ru Chen X; El Shafey N; Fréchou M; Teng F; Palmier B; Beray-Berthat V; Soustrat M; Margaill I; Plotkine M; Marchand-Leroux C; Besson VC
    Crit Care Med; 2011 Oct; 39(10):2300-7. PubMed ID: 21666443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.
    Rossi J; Rouleau L; Emmott A; Tardif JC; Leask RL
    Eur J Pharmacol; 2010 Dec; 649(1-3):268-76. PubMed ID: 20863785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells.
    Zapolska-Downar D; Siennicka A; Kaczmarczyk M; Kołodziej B; Naruszewicz M
    Life Sci; 2004 Jul; 75(11):1287-302. PubMed ID: 15234187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
    Di Napoli P; Maggi A; Spina R; Barsotti L; Taccardi AA; Stuppia L; Vianale G; Palka G; Barsotti A
    Cardiologia; 1999 Jan; 44(1):69-74. PubMed ID: 10188333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel molecular mechanism to account for the action of resveratrol against reperfusion injury.
    Namazi H
    Ann Vasc Surg; 2008; 22(3):492. PubMed ID: 18395412
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel molecular mechanism to account for action of taurine against testicular ischemia-reperfusion injury.
    Namazi H
    Urology; 2008 Aug; 72(2):465-6. PubMed ID: 18355902
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of spinal cord ischemia/reperfusion injury with simvastatin in rats.
    Saito T; Tsuchida M; Umehara S; Kohno T; Yamamoto H; Hayashi J
    Anesth Analg; 2011 Sep; 113(3):565-71. PubMed ID: 21680858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
    Lefer AM; Scalia R; Lefer DJ
    Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
    [No Abstract]   [Full Text] [Related]  

  • 17. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice.
    Rydgren T; Vaarala O; Sandler S
    J Pharmacol Exp Ther; 2007 Oct; 323(1):180-5. PubMed ID: 17636011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibodies against neutrophil and endothelial adhesion molecules on reperfusion injury after pulmonary ischemia.
    Imaizumi T
    Transplant Proc; 1994 Aug; 26(4):1851-4. PubMed ID: 7915051
    [No Abstract]   [Full Text] [Related]  

  • 19. Simvastatin improves endothelial function in patients with rheumatoid arthritis.
    Hermann F; Forster A; Chenevard R; Enseleit F; Hürlimann D; Corti R; Spieker LE; Frey D; Hermann M; Riesen W; Neidhart M; Michel BA; Hellermann JP; Gay RE; Lüscher TF; Gay S; Noll G; Ruschitzka F
    J Am Coll Cardiol; 2005 Feb; 45(3):461-4. PubMed ID: 15680730
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular effects of diet and statin in hypercholesterolemic patients.
    Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
    Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.